The clinical trial programme for semaglutide 2.4 mg (STEP trials), which included over 4,500 participants followed for up to 68 weeks as documented in the European Public Assessment Report (EPAR), did not identify diverticulitis as a treatment-emergent adverse event occurring at rates higher than placebo
Ras/Raf-1/MAPK pathway mediates response to tamoxifen but not chemotherapy in breast cancer patients
Insulin resistance and compensatory hyperinsulinemia stimulate ovarian androgen production and suppress hepatic SHBG synthesis
Immune effects are restorative, not overstimulating: It rebalances T-cell ratios, upregulates IL-2 in aged tissues, and improves neuroimmune integration, suggesting a targeted recalibration of immune tone rather than indiscriminate boosting. It restores circadian and hormonal rhythms: By stimulating melatonin synthesis, protecting pineal structure, and re-entraining clock genes, Epitalon may counter the widespread circadian drift of aging, with implications far beyond sleep, touching immunity, metabolism, and neuroprotection